Bottom line
How much do IDNA and SWHFX overlap?
18% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 26.8% of IDNA's assets and 14.9% of SWHFX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings IDNA and SWHFX have in common
| Holding | % of IDNA | % of SWHFX | Overlap |
|---|---|---|---|
| Incyte Corporation | 4.23% | 1.37% | 1.37% |
| Merck & Co., Inc. | 3.91% | 4.98% | 3.91% |
| Vertex Pharmaceuticals Incorporated | 3.87% | 1.89% | 1.89% |
| Roche Holding AG | 3.85% | 2.29% | 2.29% |
| Ipsen Sa | 3.84% | 1.34% | 1.34% |
| Gsk Plc | 3.63% | 1.73% | 1.73% |
| Sanofi Sa | 3.46% | 1.31% | 1.31% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IDNA
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Regeneron Pharmaceuticals, Inc. — 4.35%
- Genmab A/s — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- BioNTech SE — 3.73%
- Exelixis, Inc. — 3.65%
- IDEAYA Biosciences Inc — 3.36%
- Immunitybio Inc — 3.07%
- Arcus Biosciences, Inc. — 2.68%
- Caris Life Sciences, Inc. — 2.19%
- Ono Pharmaceutical Co., Ltd. — 1.91%
Only in SWHFX
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
- Thermo Fisher Scientific Inc — 2.16%
- Stryker Corp — 2.11%
- Boston Scientific Corp — 1.60%
- Abbott Laboratories — 1.60%
- Cigna Group/The — 1.51%
- Danaher Corp — 1.47%
Asset mix
| Asset type | IDNA | SWHFX |
|---|---|---|
| Stocks | 96.0% | 99.0% |
| Cash & short-term funds | 10.5% | — |
| Other | 3.8% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | IDNA | SWHFX |
|---|---|---|
| US | 70.2% | 78.6% |
| DE | 8.5% | — |
| FR | 7.8% | 2.6% |
| JP | 6.0% | 2.3% |
| CH | 5.4% | 5.2% |
| IE | — | 4.5% |
| DK | 4.2% | 0.7% |
| GB | 3.7% | 3.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IDNA and SWHFX overlap?
What stocks do IDNA and SWHFX have in common?
Should I own both IDNA and SWHFX?
Which holds more stocks, IDNA or SWHFX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.